Skip to main content
Log in

Bioequivalence: Issues and Options

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. L. Z. Benet and J. E. Goyan. Bioequivalence and narrow therapeutic index drugs. Pharmacotherapy 15:433–40 (1995).

    CAS  PubMed  Google Scholar 

  2. V. Shah, A. Yacobi, W. Barr, D. Breimer, M. Dobrinska, E. Endrenyi, W. Fairweather, W. Gillespie, M. Gonzales, J. Hooper, L. Lesko, K. Midha, P. Noonan, R. Patnaik, and R. Williams. Evaluation of orally administered highly variable drugs and drug formulations. Pharm. Res. 13:1590–1594 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. E. Ariens and E. Wuis. Bias in pharmacokinetics and clinical pharmacology. Clin. Pharmacol. Ther. 42:361–363 (1987).

    Article  CAS  PubMed  Google Scholar 

  4. H. H. Blume and K. K. Midha. Bio International '92, Conference on Bioavailability, Bioequivalence and Pharmacokinetic Studies. J. Pharm. Sci. 82:1186–1189 (1993).

    Article  CAS  PubMed  Google Scholar 

  5. S. Qureshi, G. Caille, Y. Lacasse, and I. McGilveray. Pharmacokinetics of two entericcoated ketoprofen products in humans with or without coadministration of omeprazole and comparison with solution finding. Pharm. Res. 11:1669–1672 (1994).

    Article  CAS  PubMed  Google Scholar 

  6. Y.-H. Yan, J. Hubbard, G. McKay, and K. Midha. Stereoselective in vivo and in vitro studies on the metabolism of doxepin and n-desmethyldoxepin. Xenobiotica (in press) (1997).

  7. K. K. Midha, J. W. Hubbard, M. Rawson, and R. Schwede. The impact of stereoisomerism in a bioequivalence study on two formulations of doxepin. Eur. J. Pharm. Sci. 4:133–138 (1996).

    Article  CAS  Google Scholar 

  8. K. K. Midha, J. W. Hubbard, G. McKay, M. Rawson, and R. Schwede. Stereoselectivity in bioequivalence studies of nortriptyline. J. Pharma. Sci. 84:1265–1266 (1995).

    Article  CAS  Google Scholar 

  9. H. H. Blume, I. J. McGilveray, and K. K. Midha. Bio International '94, Conference on bioavailability, bioequivalence and pharmacokinetics studies—pre-conference satellite on in vivo/in vitro correlation. Eur. J. Pharm. Sci. 3:113–124 (1995).

    Article  CAS  Google Scholar 

  10. K. K. Midha, J. W. Hubbard, P. K.-F. Yeung, E. Ormsby, G. McKay, E. M. Hawes, E. D. Korchinski, T. Gurnsey, M. J. Rawson, and R. Schwede. In K. K. Midha and H. H. Blume (eds.), Bio-International: Bioavailability, Bioequivalence and Pharmacokinetics; International Conference of F.I.P. “Bio-International '92” Medpharm Scientific Publishers, Stuttgart, 1993, pp. 53–68.

    Google Scholar 

  11. D. R. Brocks, K. J. Skeith, C. Johnston, J. Emamibafrani, P. Davis, A. S. Russell, and F. Jamali. Hematologic disposition of hydroxychloroquine enantiomers. J. Clin. Pharmacol. 34:1088–1097 (1994).

    Article  CAS  PubMed  Google Scholar 

  12. K. Midha, J. Hubbard, M. Rawson, G. McKay, and R. Schwede. The role of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: A drug with a very long half life. Eur. J. Pharm. Sci. 4:283–292 (1996).

    Article  CAS  Google Scholar 

  13. K. K. Midha, J. W. Hubbard, M. J. Rawson, and L. Gavalas. The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: Experimental evidence. Eur. J. Pharm. Sci. 2:351–363 (1994).

    Article  CAS  Google Scholar 

  14. N. R. Srinivas, W. H. Barr, W. C. Shyu, E. Mohandoss, S. Chow, J. Staggers, G. Balan, F. J. Belas, I. A. Blair, and R. H. Barbhaiya. Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: Assessment using stereospecific and nonstereospecific assays. J. Pharm. Sci. 85:299–303 (1996).

    Article  CAS  PubMed  Google Scholar 

  15. A. Karim. Enantioselective assays in comparative bioavailability studies of racemic drug formulations: Nice to know or need to know? J. Clin. Pharmacol. 36:490–499 (1996).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Midha, K.K., Rawson, M.J. & Hubbard, J.W. Bioequivalence: Issues and Options. J Pharmacokinet Pharmacodyn 25, 743–752 (1997). https://doi.org/10.1023/A:1025785902230

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025785902230

Keywords

Navigation